These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3502349)

  • 1. [New technology of vaccine production--international prospect of the development. Synthetic peptide vaccines and protein engineering].
    Aimoto S; Sakiyama F
    Nihon Rinsho; 1987 Oct; 45(10):2349-54. PubMed ID: 3502349
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells.
    Borras-Cuesta F; Petit-Camurdan A; Fedon Y
    Eur J Immunol; 1987 Aug; 17(8):1213-5. PubMed ID: 2442000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. a. Vaccinia vector vaccine].
    Hashizume S; Morita M; Takahashi F
    Nihon Rinsho; 1987 Oct; 45(10):2333-41. PubMed ID: 3482288
    [No Abstract]   [Full Text] [Related]  

  • 4. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. b. Trials of development of recombinant vaccinia polyvaccines].
    Yasuda A; Kojima A
    Nihon Rinsho; 1987 Oct; 45(10):2342-8. PubMed ID: 3129603
    [No Abstract]   [Full Text] [Related]  

  • 5. [New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. a. Application of genetic engineering using Saccharomyces cerevisiae].
    Sakamoto S
    Nihon Rinsho; 1987 Oct; 45(10):2322-5. PubMed ID: 3329247
    [No Abstract]   [Full Text] [Related]  

  • 6. Peptide vaccines for viral diseases.
    Francis MJ
    Sci Prog; 1990; 74(293 Pt 1):115-30. PubMed ID: 2267573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current trends in the development of vaccines].
    Zwisler O
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):165-74. PubMed ID: 2859720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.
    Berzofsky JA; Pendleton CD; Clerici M; Ahlers J; Lucey DR; Putney SD; Shearer GM
    J Clin Invest; 1991 Sep; 88(3):876-84. PubMed ID: 1715888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic peptides: prospects for vaccine development.
    Milich DR
    Semin Immunol; 1990 Sep; 2(5):307-15. PubMed ID: 2134015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral peptide immunogens: current challenges and opportunities.
    Azizi A; Diaz-Mitoma F
    J Pept Sci; 2007 Dec; 13(12):776-86. PubMed ID: 17853502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB; Ilyichev AA; Eroshkin AM; Karpenko LI; Pokrovsky AG; Pereboev AV; Svyatchenko VA; Ignat'ev GM; Smolina MI; Melamed NV; Lebedeva CD; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):129-37. PubMed ID: 8717396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene technology in the diagnosis of viruses and vaccine development].
    Löwer J
    Arzneimittelforschung; 1988 Mar; 38(3A):438-41. PubMed ID: 3134900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides.
    Macfarlan RI; Dietzschold B; Wiktor TJ; Kiel M; Houghten R; Lerner RA; Sutcliffe JG; Koprowski H
    J Immunol; 1984 Nov; 133(5):2748-52. PubMed ID: 6332859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of hepatitis delta virus infection by vaccination with synthetic peptides: a preliminary study in the woodchuck model.
    Bergmann KF; Casey JL; Tennant BC; Gerin JL
    Prog Clin Biol Res; 1993; 382():181-7. PubMed ID: 8502677
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of protective cytotoxic T cells with viral proteins.
    Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
    Kharchenko EP; Klimenko AP
    Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.